Puneet Souda
Stock Analyst at Leerink Partners
(1.96)
# 2,932
Out of 4,711 analysts
215
Total ratings
45.66%
Success rate
-0.96%
Average return
Main Sectors:
Stocks Rated by Puneet Souda
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MYGN Myriad Genetics | Downgrades: Market Perform | $30 → $21 | $13.36 | +57.19% | 7 | Dec 9, 2024 | |
| MASS 908 Devices | Downgrades: Market Perform | $12 → $4 | $2.06 | +94.17% | 6 | Nov 13, 2024 | |
| VCYT Veracyte | Maintains: Outperform | $35 → $40 | $40.89 | -2.18% | 14 | Oct 17, 2024 | |
| NTRA Natera | Maintains: Outperform | $140 → $150 | $161.88 | -7.34% | 7 | Oct 17, 2024 | |
| HOLX Hologic | Maintains: Outperform | $95 → $90 | $71.65 | +25.61% | 6 | Oct 8, 2024 | |
| WAT Waters | Upgrades: Outperform | $325 → $375 | $368.16 | +1.86% | 15 | Aug 1, 2024 | |
| CYRX Cryoport | Downgrades: Market Perform | $30 → $10 | $7.86 | +27.23% | 6 | Jul 13, 2023 | |
| TMO Thermo Fisher | Maintains: Outperform | $630 | $524.05 | +20.22% | 19 | Jul 6, 2023 | |
| CSTL Castle Biosciences | Maintains: Outperform | $50 → $35 | $27.53 | +27.13% | 11 | Jun 5, 2023 | |
| A Agilent Technologies | Maintains: Outperform | $170 → $145 | $134.51 | +7.80% | 19 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $300 | $228.55 | +31.26% | 1 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $249 → $250 | $136.02 | +83.80% | 19 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $125 → $110 | $73.17 | +50.33% | 6 | Feb 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $70 → $75 | $59.40 | +26.26% | 16 | Jan 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $230 → $200 | $144.46 | +38.45% | 7 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $20 → $18 | $2.85 | +531.58% | 6 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $6 | $3.50 | +71.43% | 1 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $45 → $30 | $47.94 | -37.42% | 6 | Nov 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $12 → $15 | $10.50 | +42.86% | 11 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $12 → $15 | $16.41 | -8.59% | 9 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $85 → $87 | $57.00 | +52.63% | 13 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $170 → $140 | $31.67 | +342.06% | 5 | Feb 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $20,000 → $15,000 | $0.35 | +4,285,614.29% | 5 | Jan 27, 2021 |
Myriad Genetics
Dec 9, 2024
Downgrades: Market Perform
Price Target: $30 → $21
Current: $13.36
Upside: +57.19%
908 Devices
Nov 13, 2024
Downgrades: Market Perform
Price Target: $12 → $4
Current: $2.06
Upside: +94.17%
Veracyte
Oct 17, 2024
Maintains: Outperform
Price Target: $35 → $40
Current: $40.89
Upside: -2.18%
Natera
Oct 17, 2024
Maintains: Outperform
Price Target: $140 → $150
Current: $161.88
Upside: -7.34%
Hologic
Oct 8, 2024
Maintains: Outperform
Price Target: $95 → $90
Current: $71.65
Upside: +25.61%
Waters
Aug 1, 2024
Upgrades: Outperform
Price Target: $325 → $375
Current: $368.16
Upside: +1.86%
Cryoport
Jul 13, 2023
Downgrades: Market Perform
Price Target: $30 → $10
Current: $7.86
Upside: +27.23%
Thermo Fisher
Jul 6, 2023
Maintains: Outperform
Price Target: $630
Current: $524.05
Upside: +20.22%
Castle Biosciences
Jun 5, 2023
Maintains: Outperform
Price Target: $50 → $35
Current: $27.53
Upside: +27.13%
Agilent Technologies
May 24, 2023
Maintains: Outperform
Price Target: $170 → $145
Current: $134.51
Upside: +7.80%
May 1, 2023
Initiates: Outperform
Price Target: $300
Current: $228.55
Upside: +31.26%
Feb 8, 2023
Maintains: Outperform
Price Target: $249 → $250
Current: $136.02
Upside: +83.80%
Feb 3, 2023
Maintains: Outperform
Price Target: $125 → $110
Current: $73.17
Upside: +50.33%
Jan 12, 2023
Maintains: Outperform
Price Target: $70 → $75
Current: $59.40
Upside: +26.26%
Jan 6, 2023
Maintains: Outperform
Price Target: $230 → $200
Current: $144.46
Upside: +38.45%
Jan 6, 2023
Maintains: Outperform
Price Target: $20 → $18
Current: $2.85
Upside: +531.58%
Nov 29, 2022
Initiates: Outperform
Price Target: $6
Current: $3.50
Upside: +71.43%
Nov 21, 2022
Maintains: Market Perform
Price Target: $45 → $30
Current: $47.94
Upside: -37.42%
Nov 9, 2022
Maintains: Market Perform
Price Target: $12 → $15
Current: $10.50
Upside: +42.86%
Nov 9, 2022
Maintains: Outperform
Price Target: $12 → $15
Current: $16.41
Upside: -8.59%
May 5, 2022
Maintains: Outperform
Price Target: $85 → $87
Current: $57.00
Upside: +52.63%
Feb 24, 2022
Maintains: Outperform
Price Target: $170 → $140
Current: $31.67
Upside: +342.06%
Jan 27, 2021
Maintains: Outperform
Price Target: $20,000 → $15,000
Current: $0.35
Upside: +4,285,614.29%